Jiangsu Yahong Meditech Co., Ltd. (SHA:688176)
China · Delayed Price · Currency is CNY 12.65
+0.01 (0.08%)
May 20, 2026, 1:34 PM CST
Jiangsu Yahong Meditech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -445.25 | -416.38 | -384.06 | -400.43 | -246.55 | -234.95 |
Depreciation & Amortization | 35.22 | 35.22 | 30.53 | 19.27 | 11.55 | 7.4 |
Other Amortization | 3.26 | 3.26 | 4.43 | 5.21 | 4.48 | 4.29 |
Loss (Gain) From Sale of Assets | 0 | 0 | -0.05 | - | - | 0.02 |
Asset Writedown & Restructuring Costs | 0 | 0 | - | 0.03 | 1.84 | 1.19 |
Loss (Gain) From Sale of Investments | -21.85 | -21.85 | -24.46 | -25.39 | -57.58 | -16.37 |
Provision & Write-off of Bad Debts | 2.04 | 2.04 | 2.7 | 0.45 | 0.02 | 0.29 |
Other Operating Activities | 12.18 | -2.54 | 8.28 | 3.94 | -9.07 | 2.51 |
Change in Accounts Receivable | -68.02 | -68.02 | -89.33 | -45.9 | 13.5 | -20.8 |
Change in Inventory | -14.71 | -14.71 | -3.45 | 1.15 | -0.81 | -0.79 |
Change in Accounts Payable | 53.99 | 53.99 | 11.17 | 27.22 | 33.75 | 24.96 |
Change in Other Net Operating Assets | 17.5 | 17.5 | 20.1 | 17.29 | 6.95 | 60.74 |
Operating Cash Flow | -425.94 | -411.79 | -424.95 | -398.19 | -241.96 | -171.52 |
Capital Expenditures | -22.62 | -19.12 | -5.79 | -101.63 | -26.61 | -42.4 |
Sale of Property, Plant & Equipment | 0.03 | 0.01 | 0.07 | - | - | 0 |
Investment in Securities | -227.15 | 54.86 | 804.84 | -274.89 | -1,291 | 165.73 |
Other Investing Activities | -0 | 1.87 | -1.87 | 9.72 | - | - |
Investing Cash Flow | -249.74 | 37.62 | 797.25 | -366.8 | -1,318 | 123.33 |
Short-Term Debt Issued | - | 288.05 | 66.2 | 73.4 | - | - |
Total Debt Issued | 317.55 | 288.05 | 66.2 | 73.4 | - | - |
Short-Term Debt Repaid | - | -66.2 | -73.4 | - | - | - |
Long-Term Debt Repaid | - | -19.68 | -17.26 | -11.36 | -8.99 | -4.52 |
Total Debt Repaid | -137.47 | -85.88 | -90.66 | -11.36 | -8.99 | -4.52 |
Net Debt Issued (Repaid) | 180.07 | 202.17 | -24.46 | 62.04 | -8.99 | -4.52 |
Issuance of Common Stock | 8.07 | 8.07 | - | - | - | 2,396 |
Repurchase of Common Stock | - | - | -50.06 | - | - | - |
Common Dividends Paid | -5.28 | -4.08 | -2.49 | -0.41 | - | - |
Other Financing Activities | -0.72 | - | - | 0.39 | -22.05 | -8.03 |
Financing Cash Flow | 182.15 | 206.16 | -77.01 | 62.01 | -31.05 | 2,384 |
Foreign Exchange Rate Adjustments | -2.05 | -1.68 | -1.95 | 0.76 | 7.35 | -2 |
Net Cash Flow | -495.59 | -169.69 | 293.34 | -702.22 | -1,584 | 2,334 |
Free Cash Flow | -448.56 | -430.92 | -430.74 | -499.82 | -268.57 | -213.92 |
Free Cash Flow Margin | -156.24% | -155.50% | -213.70% | -3634.18% | -1029206.22% | -4676788.98% |
Free Cash Flow Per Share | -0.80 | -0.77 | -0.76 | -0.84 | -0.47 | -0.46 |
Cash Income Tax Paid | 20.44 | 22.2 | 13.75 | 1.94 | -22.57 | -2.7 |
Levered Free Cash Flow | -320.97 | -275.37 | -271.45 | -334.62 | -204.07 | -106.45 |
Unlevered Free Cash Flow | -315.8 | -270.2 | -267.23 | -332.76 | -203.59 | -106.15 |
Change in Working Capital | -11.54 | -11.54 | -62.33 | -1.26 | 53.35 | 64.11 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.